Markets
Bone Biologics Corporation (BBLG)
BBLGNASDAQ-CMIndustrial Specialties
$0.3412
+0.0099 (+2.99%) today
At the close, Nov 10, 4:00 PM ET. After hours $0.3412 –
+2.99% 1D
- Market cap
- $1.16m
- P/E
- –
- EPS, last 4 quarters
- $-1.17
- Dividend yield
- –
- Day range
- $0.3200 to $0.3500
- 52-week range
- $0.3150 to $2.39
- Average volume
- 147.2k
- Previous close
- $0.3313
Earnings
next estimate $-0.1500Next report
Dec 2025
+58.8%
Mar 2026
+20.4%
Jun 2026
-10.3%
Sep 2026
+10.5%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$733.0k | -$805.0k | -$808.0k | -$666.0k |
| Net income | -$685.0k | -$766.0k | -$774.0k | -$618.0k |
News
6 latest- Bone Biologics Extends RhNELL-1 Shelf Life To 32 Months, Strengthening Study Readiness; Stock Down RTTNews · Aug 12, 2026
- Bone Biologics Prices Up To $9 Mln Private Placement Of Shares And Warrants;Stock Up RTTNews · Jul 8, 2026
- Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share RTTNews · Jun 27, 2025
- Why Bone Biologics Is Rising In Pre-market? RTTNews · Jun 27, 2025
- Bone Biologics To Implement 1-for-6 Reverse Stock Split Effective June 10, 2025 RTTNews · Jun 6, 2025
- BONE BIOLOGICS Earnings Results: $BBLG Reports Quarterly EarningsQuiver Quantitative · May 12, 2025
The company
Bone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking work with select strategic partners that builds on the preclinical research of the NELL-1 protein. Bone Biologics is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications.
- Sector
- Health Care
- Industry
- Industrial Specialties
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- bonebiologics.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.